Raphael Carandang to National Institute of Neurological Disorders and Stroke (U.S.)
This is a "connection" page, showing publications Raphael Carandang has written about National Institute of Neurological Disorders and Stroke (U.S.).
Connection Strength
0.518
-
Carandang RA. Thirty Years After the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Trial: A New Era for Stroke Therapy. JAMA Neurol. 2016 Mar; 73(3):265-7.
Score: 0.518